Johnson & Johnson touts antibody response for COVID-19 booster 8 months after original vaccination

Shortly after the U.S. telegraphed its booster plan for Pfizer and Moderna’s mRNA-based COVID-19 vaccines, Johnson & Johnson has rolled out trial results showing a follow-up dose of its vaccine boosts recipients' antibody responses.